Cancer and cardiovascular disease (CVD) are common causes of morbidity and mortality, and measurement and interpretation of their co-occurrence rate have important implications for public health and ...

Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...

Multidisciplinary Lung Cancer Tumor Board Connecting Eight General Hospitals in Japan via a High-Security Communication Line Treatment sequencing of metastatic breast cancer (MBC) is heterogeneous.

Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualize and activate the oxytocin receptor. This receptor—also known as the love/bonding ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that clinical data from a ...

Microscopy image of invasive breast cancer cells (labelled in yellow) degrading their underlying extracellular matrix (labelled gelatin in red, degraded areas appear as black holes). Scale bar, 20µm.

Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease's intricate and varied nature. Consequently, developing nanomedicines with ...

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company’s Phase 2, ...

Visualization in the UMAP space of samples corresponding to the subtypes ER+ (a), HER2+ (b), and TN (c). The samples were categorized by cancer subtype and integrated. Cells are color-coded according ...